McArdle disease: what do neurologists need to know?
- 1 October 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Neurology
- Vol. 4 (10) , 568-577
Abstract
McArdle disease (also known as glycogen storage disease type V) is a pure myopathy caused by an inherited deficit of myophosphorylase, the skeletal muscle isoform of the enzyme glycogen phosphorylase. The disease exhibits clinical heterogeneity, but patients typically experience exercise intolerance, that is, reversible, acute crises (early fatigue and contractures, sometimes with rhabdomyolysis and myoglobinuria) triggered by static muscle contractions (e.g. lifting weights) or dynamic exercise (e.g. climbing stairs or running). In this Review, we discuss the main features of McArdle disease, with the aim of providing neurologists with up-to-date, useful information to assist their patients. The topics covered include diagnostic tools—for example, molecular genetic diagnosis, the classic ischemic forearm test and the so-called 'second wind' phenomenon—and current therapeutic options—for example, a carbohydrate-rich diet and carbohydrate ingestion shortly before strenuous exercise, in combination with medically supervised aerobic training of low to moderate intensity.Keywords
This publication has 66 references indexed in Scilit:
- Genotype modulators of clinical severity in McArdle diseaseNeuroscience Letters, 2007
- Favorable Responses to Acute and Chronic Exercise in McArdle PatientsClinical Journal of Sport Medicine, 2007
- A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle diseaseMolecular Genetics and Metabolism, 2005
- The Effect of Oral Sucrose on Exercise Tolerance in Patients with McArdle's DiseaseNew England Journal of Medicine, 2003
- Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: A noninvasive 31P‐MRS and EMG studyMuscle & Nerve, 2003
- Phenotype modulators in myophosphorylase deficiencyAnnals of Neurology, 2003
- Myophosphorylase Deficiency (Glycogenosis Type V McArdle Disease)Current Molecular Medicine, 2002
- Treatment of McArdle DiseaseArchives of Neurology, 2000
- Reduced levels of skeletal muscle Na + K + -ATPase in McArdle diseaseNeurology, 1998
- Molecular Genetic Heterogeneity of Myophosphorylase Deficiency (McArdle's Disease)New England Journal of Medicine, 1993